Differential Binding of Tenofovir and Adefovir to Reverse Transcriptase of Hepatitis B Virus

Differential Binding of Tenofovir and Adefovir to Reverse Transcriptase of Hepatitis B Virus

Bibliographic Details
Main Authors:	van Hemert, Formijn J., Berkhout, Ben, Zaaijer, Hans L.
Format:	Online
Language:	English
Published:	Public Library of Science 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152281/

Similar Items

Nucleotide composition of the Zika virus RNA genome and its codon usage
by: van Hemert, Formijn, et al.
Published: (2016)

The Hepatitis B Virus X Protein Inhibits Thymine DNA Glycosylase Initiated Base Excision Repair
by: van de Klundert, Maarten A. A., et al.
Published: (2012)

Protein X of Hepatitis B Virus: Origin and Structure Similarity with the Central Domain of DNA Glycosylase
by: van Hemert, Formijn J., et al.
Published: (2011)

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
by: Park, Jung Gil, et al.
Published: (2015)

Comparison of the efficacy of tenofovir and adefovir in the treatment of chronic hepatitis B: A Systematic Review
by: Zhao, Shu-Shan, et al.
Published: (2011)

Laboratory Evaluation of Three Regimens of Treatment of Chronic Hepatitis B: Tenofovir, Entecavir and Combination of Lamivudine and Adefovir
by: Jayakumar, Rajeswari, et al.
Published: (2012)

Lamivudine plus tenofovir versus lamivudine plus adefovir for the treatment of hepatitis B virus in HIV-coinfected patients, starting antiretroviral therapy
by: Jayeeta Sarkar, et al.
Published: (2018-01-01)

Different rates of (non-)synonymous mutations in astrovirus genes; correlation with gene function
by: van Hemert, Formijn J, et al.
Published: (2007)

Effect of Hepatitis B Virus Genotypes on the Efficacy of Adefovir Dipivoxil Antiviral Therapy
by: Wen, Zhili, et al.
Published: (2014)

Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant
by: Ratziu, Vlad, et al.
Published: (2006)

Pre-Existing Mutations in Reverse Transcriptase of Hepatitis B Virus in Treatment-Naive Chinese Patients with Chronic Hepatitis B
by: Xu, Jie, et al.
Published: (2015)

Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations
by: Cassino, Lucila, et al.
Published: (2011)

Analysis for clinical efficacy and virological evolution during sequential entecavir plus adefovir combination and tenofovir ± entecavir therapies in entecavir-resistant chronic hepatitis B patients
by: Jin-man SHAO, et al.
Published: (2018-05-01)

Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice
by: Lin, Ming-Tsung, et al.
Published: (2016)

Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase
by: Nakamura, Akiyoshi, et al.
Published: (2015)

NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities
by: Thammaporn, Ratsupa, et al.
Published: (2015)

Nephrogenic hypophosphatemic osteomalacia during adefovir monotherapy for chronic hepatitis B monoinfection
by: Xu, Yaowen, et al.
Published: (2013)

Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection
by: Duwal, Sulav, et al.
Published: (2012)

Correction: Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection
by: Duwal, Sulav, et al.
Published: (2012)

HIV-1 tolerates changes in A-count in a small segment of the pol gene
by: Bep Klaver, et al.
Published: (2017-09-01)

The A-nucleotide preference of HIV-1 in the context of its structured RNA genome
by: van Hemert, Formijn J., et al.
Published: (2013)

The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
by: Kim, Jeong Han, et al.
Published: (2016)

Analysis of Reverse Transcriptase Gene Mutations in the Hepatitis B Virus at a University Hospital in Korea
by: Lee, A-Jin, et al.
Published: (2014)

Novel Natural Mutations in the Hepatitis B Virus Reverse Transcriptase Domain Associated with Hepatocellular Carcinoma
by: Wu, Yan, et al.
Published: (2014)

Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention
by: Jones, Scott A, et al.
Published: (2013)

Re-discussion on features of clinical occurrence and implications of hepatitis B virus mutations in reverse transcriptase/surface antigen genes
by: Yan LIU, et al.
Published: (2018-05-01)

Modeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interaction
by: Xu, Xiaojun, et al.
Published: (2016)

Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma
by: Yang, Xunjun, et al.
Published: (2016)

Modeling and Simulating Dynamics of Complete- and Poor-Response Chronic Hepatitis B Chinese Patients for Adefovir and Traditional Chinese Medicine Plus Adefovir Therapy
by: Min, Lequan, et al.
Published: (2013)

Delayed Reduction of Hepatitis B Viral Load and Dynamics of Adefovir-Resistant Variants during Adefovir plus Entecavir Combination Rescue Therapy
by: Wang, Yang, et al.
Published: (2015)

Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections
by: Lin, Ming-Tsung, et al.
Published: (2013)

Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients
by: Pereira-Gómez, Marianoel, et al.
Published: (2016)

Antiviral Efficacy of Entecavir versus Entecavir plus Adefovir for Hepatitis B Virus rtA181V/T Mutants Alone
by: Oh, Myung Jin, et al.
Published: (2016)

Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy
by: WANG, YANG, et al.
Published: (2016)

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
by: Woo, Hyun Young, et al.
Published: (2014)

A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol
by: Xie, Wen, et al.
Published: (2011)

A comparison of treatment with adefovir and entecavir for chronic hepatitis B in China: The 2-year results of a prospective study: Adefovir versus Entercavir for Chronic Hepatitis B
by: Chen, En Qiang, et al.
Published: (2011)

Identification of RNA binding motifs in the R2 retrotransposon-encoded reverse transcriptase
by: Jamburuthugoda, Varuni K., et al.
Published: (2014)

Hepatitis B Virus Protein X Induces Degradation of Talin-1
by: van de Klundert, Maarten A. A., et al.
Published: (2016)

Evaluation of adefovir & lamivudine in chronic hepatitis B: Correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis
by: Pradeep, Kumar S, et al.
Published: (2011)